October 22nd, 2023

On Tuesday, October 24, an array of notable companies is gearing up to unveil their financial results, including: Visa Inc. (NYSE: V), a major player in the global payment technology sector, is poised to disclose its fiscal fourth quarter and full. Read more

July 18th, 2023

Shares of Novartis AG (NYSE: NVS) experienced a surge in premarket trading as the company surpassed expectations in its second-quarter 2023 financial report.  The pharmaceutical giant reported core earnings per share (EPS) of $1.83 and sales . Read more

July 16th, 2023

On Tuesday, July 18, several companies are expected to report their financial results, including: Bank of America Corporation (NYSE: BAC), a financial giant, is set to reveal its second-quarter 2023 financial results before the market opens. . Read more

June 12th, 2023

Pharvaris N.V. (Nasdaq: PHVS) released data from their Phase 2 study, RAPIDe-1, evaluating the on-demand treatment of hereditary angioedema (HAE) attacks with PHVS416 (deucrictibant immediate-release capsules). The study showed that treatment with. Read more

June 01st, 2023

Dollar General Corporation (NYSE: DG), a leading discount retailer, reported first-quarter fiscal 2023 earnings per share (EPS) of $2.34, slightly below the consensus estimate of $2.38.  The company acknowledged a more challenging macroeconom. Read more

May 22nd, 2023

AVROBIO, Inc. (Nasdaq: AVRO) has made a significant announcement, revealing that it has entered into an agreement to sell its investigational hematopoietic stem cell (HSC) gene therapy program for the treatment of cystinosis to Novartis (NYSE: NVS). . Read more